Back to search
FDAFDA · Food and drugs·Recall number D-0009-2016

Bromfenac Ophthalmic Solution 0.09%, packaged in a) 1.7 mL bottle (NDC 60505-0595-05), b) 2.5 mL bottle (NDC 60505-0596-04), Rx Only, Mfg for: Apotex Corp., Weston, FL 33326.

Published October 21, 2015 · Recall initiated: August 25, 2015

Summary

FDA records drug Class II recall D-0009-2016, published October 21, 2015 and initiated August 25, 2015. Recalling firm: Apotex Inc.; Status: Terminated; Reported quantity: 5,520 bottles (Lot MF0537), 2,828 bottles (Lot MF8090), and 20,454 bottles (Lot MF0532); Lot: Lot #: a) MF0537, Exp 07/2016; b) MF8090, MF0532, Exp 07/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Failed preservative effectiveness testing

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apotex Inc.
Distributor
Nationwide
Lot
Lot #: a) MF0537, Exp 07/2016; b) MF8090, MF0532, Exp 07/2016
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Bromfenac Ophthalmic Solution 0.09%, packaged in a) 1.7 mL bottle (NDC 60505-0595-05), b) 2.5 mL bottle (NDC 60505-0596-04), Rx Only, Mfg for: Apotex Corp., Weston, FL 33326. recalled?

Yes. FDA published recall D-0009-2016 on October 21, 2015. Reported hazard: Lack of Assurance of Sterility: Failed preservative effectiveness testing

What should I do if I have this product?

Voluntary: Firm initiated · Letter